Mankind Pharma Ltd. (MANKIND)
BSE
Closed
Oct 9, 2026
Day's Range
2,340.7552 wk Range
1,909.90Overview - MANKIND - Mankind Pharma Ltd.
Key Statistics
Valuation
Enterprise Value
1.07T
P/E (Trailing)
‪47.92‬
P/E (Forward)
‪33.33‬
PEG Ratio
‪1.37‬
Price / Sales (TTM)
‪6.63‬
Price / Book
‪5.99‬
EV / EBITDA
‪27.60‬
Profitability
Gross Margin
‪72.75%‬
Profit Margin
‪13.85%‬
Operating Margin
‪20.60%‬
Return on Assets
‪6.81%‬
Return on Equity
‪11.55%‬
Ownership
Shares Outstanding
413.04M
Float
112.99M
Held by Insiders
‪75.39%‬
Held by Institutions
‪18.79%‬
Price stats
Beta
‪0.44‬
50-Day Avg
‪2,415.04‬
200-Day Avg
‪2,298.43‬
Dividends
Payout Ratio
‪2.02%‬
Analyst Consensus
19 analysts
Average price target
‪₹ 2,741.74‬Market Cap - MANKIND - Mankind Pharma Ltd.
Peers - MANKIND - Mankind Pharma Ltd.
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on BSE.
- MANKINDBSEMankind Pharma Ltd.978.50BMarket Cap-3.07%52-week change47.92P/E (Trailing)‪13.85%‬Profit Margin
- DIVISLABBSEDivi's Laboratories Ltd.2.47TMarket Cap+29.72%52-week change84.62P/E (Trailing)‪26.04%‬Profit Margin
- LAURUSLABSBSELaurus Labs Ltd.1.07TMarket Cap+56.59%52-week change98.03P/E (Trailing)‪15.04%‬Profit Margin
- CIPLABSECipla Ltd.1.05TMarket Cap-20.00%52-week change23.19P/E (Trailing)‪16.25%‬Profit Margin
- DRREDDYBSEDr. Reddy's Laboratories Ltd.1.00TMarket Cap-2.69%52-week change17.73P/E (Trailing)‪16.36%‬Profit Margin
- AUROPHARMABSEAurobindo Pharma Ltd.980.78BMarket Cap+32.58%52-week change27.88P/E (Trailing)‪10.52%‬Profit Margin
- LUPINBSELupin Ltd.895.65BMarket Cap-0.53%52-week change20.77P/E (Trailing)‪17.47%‬Profit Margin
Profile Summary - MANKIND - Mankind Pharma Ltd.
About
Mankind Pharma Ltd. is a prominent pharmaceutical company based in India, focusing on the development, manufacturing, and marketing of a diverse range of pharmaceutical products. The company is recognized for its extensive portfolio that includes prescription medications, over-the-counter products, and a variety of…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
